Beyond care gap closure: Rethinking clinical strategy in Medicare Advantage

Closing care gaps has become a core focus for Medicare Advantage plans for good reason. Gap closure directly impacts Star Ratings, quality performance, and reimbursement. It’s measurable, actionable, and tied to clear programmatic goals.

For many Medicare Advantage plans, it has also become the end point of clinical strategy rather than the starting point. That’s a problem.

In today’s environment, where performance expectations are rising, margins are tightening, and member populations are increasingly complex, closing care gaps alone is no longer enough to drive meaningful improvement.

The health plans that outperform aren’t just closing gaps. They’re completely rethinking how clinical strategy works.

The limits of a gap-closure–first approach

Traditional Medicare Advantage care gap programs are inherently reactive. They identify missed screenings, incomplete documentation, or overdue interventions, often well after the opportunity to influence outcomes has passed. Outreach follows, gaps are addressed, and performance improves incrementally. But this approach creates structural limitations:

• Interventions come late in the care journey
• Impact is episodic, not continuous
• Clinical and financial outcomes remain disconnected
• High-risk populations are managed broadly, not precisely

Even when executed well, gap closure alone cannot fully address avoidable utilization, rising costs, or the complexity of chronic populations. It improves performance, but it doesn’t fundamentally change it.

Why clinical strategy needs to evolve

Medicare Advantage plans are now operating in a far more dynamic environment:

• Star Ratings increasingly depend on longitudinal member experience and outcomes
• Value-based contracts require predictable performance across populations
• Chronic conditions and social risk factors demand earlier, more targeted intervention

At the same time, the data needed to manage this complexity already exists across clinical systems, claims, quality measures, and risk models.

The challenge isn’t access to data. It’s the ability to connect it, interpret it, and act on it in time to change outcomes. Too often, insights remain fragmented:

• Quality teams focus on HEDIS^® and Star Ratings
• Risk adjustment teams focus on RAF accuracy
• Care management focuses on interventions
• Finance evaluates cost and utilization

Each function is optimizing its own outcomes, but no one is fully aligned around how clinical strategy drives enterprise performance. The result is a familiar pattern: strong effort, incremental gains, and missed opportunity.

From reactive intervention to proactive clinical strategy

Leading Medicare Advantage plans are taking a different approach. They are moving beyond care gap closure and toward a more proactive, data-driven model of clinical strategy that focuses not just on what needs to be fixed, but on what will drive the greatest impact moving forward.

This shift includes four key changes:

1. From gaps to risk trajectories: Instead of focusing only on open gaps, leading health plans identify which members are most likely to experience adverse outcomes before those outcomes occur. This enables earlier intervention, better prioritization, and more effective care management.
2. From retrospective reporting to real-time insight: Rather than analyzing performance after the fact, health plans are using integrated data to monitor risk, utilization, and quality signals continuously. This allows teams to act sooner when interventions are more likely to succeed.
3. From broad programs to targeted action: Not all members and not all interventions deliver equal value. High-performing health plans prioritize actions based on clinical risk, potential impact, and likelihood of success, ensuring resources are focused where they matter most.
4. From siloed execution to aligned outcomes: Clinical strategy is no longer owned by a single function. Instead, it connects:

• Risk adjustment (RAF accuracy and coding completeness)
• Quality performance (Star Ratings and HEDIS)
• Utilization management (cost and avoidable events)
• Care management (interventions and outcomes)

When these are aligned, health plans can drive improvements that are both clinically meaningful and financially measurable.

The impact: Better outcomes, lower cost, stronger performance

This shift from reactive to proactive clinical strategy changes what’s possible. Instead of closing gaps at the end of the process, health plans can:

• Reduce avoidable hospitalizations and utilization through earlier intervention
• Improve Star Ratings performance by addressing drivers upstream
• Increase RAF accuracy and revenue capture with more complete clinical insight
• Enhance outcomes for high-risk and chronic populations through targeted care

Most importantly, they move from isolated improvements to sustained, scalable performance.

What makes this shift possible

Executing this strategy requires more than incremental process improvement. It requires a fundamentally different approach to data and decision-making.

Leading health plans are investing in the ability to:

• Unify clinical, claims, financial, and quality data into a single, trusted view
• Identify emerging risks and opportunities in near real time
• Prioritize interventions based on expected impact
• Embed insights directly into workflows and care programs

This is where many health plans struggle. Despite significant investment in analytics, insights often remain disconnected from execution. They are identified in reports but not operationalized in time to influence outcomes.

Closing this gap between insight and action is what enables clinical strategy to evolve from reactive to proactive and from incremental improvement to measurable impact.

From closing gaps to driving performance

Care gap closure will always be important. It remains a critical component of quality programs and Star Ratings performance. But it is no longer enough on its own. The future of Medicare Advantage performance will be defined by organizations that:

• Act earlier
• Prioritize smarter
• Align clinical and financial outcomes
• And continuously optimize performance across populations

The opportunity for clinical leaders is clear: Move beyond closing gaps and start building a strategy that anticipates risk, drives action, and delivers measurable results.

Interested in reading more on this topic? Check out our eBook: “From good to great: Eight steps to improve Medicare Advantage Star Ratings.”